Disease burden and quality of life of patients with chronic urticaria in Spain. Prevalence of chronic urticaria refractory to standard therapy in routine clinical practice. UCREX study.
Researchers
-
Albert González Martin
Dermatologist
-
Anna Ravella Matthew
Dermatologist
PhD -
David Vidal Sarro
Dermatologist
PhD -
Gisela Hebe Petiti
Dermatologist
-
Joan Antoni Smandia Domínguez
Dermatologist
PhD -
Laura Peramiquel Fonollosa
Dermatologist
-
Loida Galvany Rosell
Dermatologist
-
Mª Rosa Olivella Garcés
Dermatologist
-
Maria López Nuñez
Dermatologist
-
Maria Villar Buil
Dermatologist
-
Nuria Lamas Domenech
Dermatologist
Contact the group
Form-
Rozas-Muñoz E, Gallardo F, Pujol RM, Pérez-Ferriols A, Servitje O, Estrach T, Bastida J, Román C, Palacio-Aller L, Gil I, Martí RM, Vidal-Sarró D, García-Muret MP. 30/18
Extranodal natural killer/T-cell lymphoma, nasal type: a Spanish multicentric retrospective survey.
Eur J Dermatol. 2018;28(1):64-70.
-
Spertino J, Rozas Muñoz E, Curto Barredo L, Figueras Nart I, Gimenez Arnau A, Serra Baldrich E, Bonfill-Ortí M, Expósito-Serrano V, Guilabert A, Melé Ninot G, Villar Buil M, Garcias Ladaria J, García Navarro X, Vilavella M, Bielsa Marsol I, Aparicio Ortiz G, Baliu Piqué C, Álvarez Abella A, Lamas Domenech N, Mascaró JM, Gómez S, Torné Gutiérrez JI, Vicente Villa A. 31/1831/18
Treatment algorithm with omalizumab in spontaneous chronic urticaria.
Actas Dermosifiliogr. 2018;109:771-776.
-
Notario J, Deza G, Vilarrasa E, Valentí F, Muñoz C, Mollet J, Rocamora V, Carrascosa J, Alcázar E, Alsina M, Vidal D, Puig L, López-Ferrer A, Riera J, Gallardo F, Ferran M. 29/18
Treatment of patients with plaque psoriasis with secukinumab in a real-life setting: a 52-week, multicenter, retrospective study in Spain.
J Dermatologist Treat. 2018:1-21.
-
Rozas-Muñoz E, Gallardo F, Pujol RM, Pérez-Ferriols A, Servitje O, Estrach T, Bastida J, Román C, Palacio-Aller L, Gil I, Martí RM, Vidal-Sarró D, García-Muret MP. 30/18
Extranodal natural killer/T-cell lymphoma, nasal type: a Spanish multicentric retrospective survey.
Eur J Dermatol. 2018;28(1):64-70.
-
Spertino J, Rozas Muñoz E, Curto Barredo L, Figueras Nart I, Gimenez Arnau A, Serra Baldrich E, Bonfill-Ortí M, Expósito-Serrano V, Guilabert A, Melé Ninot G, Villar Buil M, Garcias Ladaria J, García Navarro X, Vilavella M, Bielsa Marsol I, Aparicio Ortiz G, Baliu Piqué C, Álvarez Abella A, Lamas Domenech N, Mascaró JM, Gómez S, Torné Gutiérrez JI, Vicente Villa A. 31/18
Treatment algorithm with omalizumab in spontaneous chronic urticaria.
Actas Dermosifiliogr. 2018;109:771-776.
-
García-Gavín J, Pérez-Pérez L, Tinazzi I, Vidal D, McGonagle D. 1416
Cultural adaptation to Spanish of the questionnaire Early Arthritis for Psoriatic patients.
Actas Dermosifiliogr. 2017;108:924-30.
-
García-Gavín J, Pérez-Pérez L, Tinazzi I, Vidal D, McGonagle D. 1416
Cultural adaptation to Spanish of the questionnaire Early Arthritis for Psoriatic patients.
Actas Dermosifiliogr. 2017;108:924-30.
-
Carrascosa JM, de la Cueva P, Ara M, Puig L, Bordas X, Carretero G, Ferrándiz L, Sánchez-Carazo JL, Daudén E, López-Estebaranz JL, Vidal D, Herranz P, Jorquera E, Coto-Segura P, Ribera M. 1322
Methotrexate in moderate-severe psoriasis: literature review and expert recommendations.
Actas Dermosifiliogr. 2016;107:194-206.
-
Vidal D, Ruiz R, Alfageme F, Roustan G, Mollet J, Ruiz-Carrascosa JC, Habicheyn S, Gavín J, Arias-Santiago S, Martorell-Calatayud A, Velasco-Pastor M. 1323
Use of high frequency ultrasonography in dermatology departments in Spain.
Dermatology Online Journal. 2016;22:4.
-
Torrente-Segarra V, Petiti GH, González A, Corominas H. 1344
Active tenosynovitis of the palmar flexor tendon in psoriatic arthritis in clinical remission.
Reumatol Clin. 2016;12(4):230-2.
Projects
-
- Year 2019
- Sant Joan Despí Moisès Broggi Hospital
I study SPRING. Multicenter retrospective study of routine clinical practice in patients with moderate to severe psoriasis treated with Guselkumab.
-
DISTRICT ATTORNEY:
Janssen‐Cilag SA
-
TYPE E:
EPA-OD
-
Dermatologist
Researcher
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
Study of the efficacy and safety of Ixekizumab in patients with moderate-severe psoriasis in real clinical practice: multicenter, observational, retrospective study.
-
DISTRICT ATTORNEY:
Jaume Notary Rosa. Dermatology Service. Bellvitge University Hospital
-
TYPE E:
EPA
-
Dermatologist
Researcher
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
Study of Health Outcomes in Psoriasis (PSoHO): international observational study of health outcomes during 3 years on the biological treatment of psoriasis in moderate to severe plaques.
-
DISTRICT ATTORNEY:
Eli Lilly and Company
-
TYPE E:
EPA
-
Dermatologist
Researcher
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
Multicenter, randomized, double-blind, secukinumab-controlled and parallel-group study to evaluate the efficacy and safety of bimekizumab in adults with moderate or severe chronic plaque psoriasis.
-
DISTRICT ATTORNEY:
UCB Biopharma SPRL
-
TYPE E:
RD2015
-
Dermatologist
Researcher
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
Observational, non-interventional, transversal and retrospective, multicenter study to evaluate the quality of life in real clinical practice conditions in patients with moderate-severe psoriasis treated with methotrexate in Spain.
-
DISTRICT ATTORNEY:
Novartis Farmacéutica, SA
-
TYPE E:
EPA
-
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
Study of the efficacy and safety of Ixekizumab in patients with moderate-severe psoriasis in real clinical practice: multicenter, observational, retrospective study.
-
DISTRICT ATTORNEY:
Jaume Notary Rosa. Dermatology Service. Bellvitge University Hospital
-
TYPE E:
EPA
-
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
Study of Health Outcomes in Psoriasis (PSoHO): international observational study of health outcomes during 3 years on the biological treatment of psoriasis in moderate to severe plaques.
-
DISTRICT ATTORNEY:
Eli Lilly and Company
-
TYPE E:
EPA
-
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
Multicenter, randomized, double-blind, secukinumab-controlled and parallel-group study to evaluate the efficacy and safety of bimekizumab in adults with moderate or severe chronic plaque psoriasis.
-
DISTRICT ATTORNEY:
UCB Biopharma SPRL
-
TYPE E:
RD2015
-
- Year 2018
- Sant Joan Despí Moisès Broggi Hospital
Observational, non-interventional, transversal and retrospective, multicenter study to evaluate the quality of life in real clinical practice conditions in patients with moderate-severe psoriasis treated with methotrexate in Spain.
-
DISTRICT ATTORNEY:
Novartis Farmacéutica, SA
-
TYPE E:
EPA
-
Dermatologist
Researcher
- Year 2017
- Sant Joan Despí Moisès Broggi Hospital
Search for genetic markers predictors of response to new drugs in the treatment of psoriasis.
-
DISTRICT ATTORNEY:
Dr. Esteban Daudén Tello
-
TYPE E:
EPA
- Immune mediated skin diseases
- Skin cancer
- neurofibromatosis
- Ultrasonography
